Brendan McDermid/Reuters
Billionaire Carl Icahn has taken a stake in the pharmaceutical company Bristol-Myers and sees it as a possible takeover target, according to The Wall Street Journal.
Bristol-Myers shares gained as much as 5% in late trading on Tuesday after the news crossed.
Bristol-Myers announced earlier Tuesday an expanded share-buyback program, and named three new board members, following pressure from activist investor Jana Partners. The companies had been in talks since Jana Partners became a shareholder in the fourth quarter, Bristol-Myers said.
Icahn sees value in the company's pipeline of drugs which currently includes treatments for heart diseases and cancer, the report said.
NOW WATCH: Mexican architects visualized Trump's proposed $25 billion wall to show how unrealistic it would be
See Also:
- These courses can help you master the single most powerful tool in Excel
- I’ve tested over 100 headphones in the past year, and I keep coming back to this $26 pair
- This little-known Amazon service turns stuff you want to get rid of into store credit
SEE ALSO: Bristol-Myers slashes its 2017 outlook
